Quebec · CCAA
5 Approval and reverse vesting order - February 4, 2025
Reverse vesting order · 4 February 2025
AI summary
A plain-English summary drawn only from this filing: what it is, why it matters, and the parties, amounts and dates it turns on.
What we verified from this filing7 verified
- closing termsClosing steps to occur in the manner, order and sequence specified in Schedule E of the Purchase Agreement
- order date4 February 2025
- presiding officerJustice David R. Collier
- purchaserXediton Pharmaceuticals Inc.
- residualcoResidualCo
- sale outcometext: The Court approves the Purchase and Sale Transactions and the Reorganization as described in the Purchase Agreement. · scope: whole_business · status: approved
- sealed itemsunredacted Purchase Agreement and amendment thereto